http://www.aktiencheck.de aktiencheck.de aktiencheck.de Fri, 08 May 2026 07:33:19 +0200 2 http://www.aktiencheck.de/forum/Vitrolife_WKN_676901_VITR_alter_Schwede-676901-t545046 http://www.aktiencheck.de/forum/Vitrolife_WKN_676901_VITR_alter_Schwede-676901-t545046 Zahlen waren für die Bewertung wohl nicht positiv, Report on operations 2017: Continued profitable growth 2018-02-08 - 08:30 Fourth quarter: Sales amounted to SEK 271 (251) million, corresponding to an increase of 8 percent in SEK. Sales growth was 11 percent in local currency and consisted in its entirety of organic growth. Operating income before depreciation and amortisation (EBITDA) amounted to SEK 103 (96) million, corresponding to a margin of 38 (38) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 5 million. Net income amounted to SEK 69 (60) million, which gave earnings per share of SEK 3.15 (2.74). www.vitrolife. [<a href="http://www.aktiencheck.de/forum/Vitrolife_WKN_676901_VITR_alter_Schwede-676901-t545046">mehr</a>]